Target intelligence / Profile preview

Mas proto-oncogene G protein-coupled receptor–Dopamine receptor D2 heteromer (Mas-D2R heteromer)

Target
Mas-D2R heteromer
Molecular classification
G protein-coupled receptor, Receptor complex
01

Overview

The Mas proto-oncogene G protein-coupled receptor–Dopamine receptor D2 (Mas-D2R) heteromer is a functional protein complex formed by the physical association of the Mas receptor (MAS1) and the Dopamine D2 receptor (D2R) (Li et al., 2014, Hypertension). This heteromer is primarily localized in the renal proximal tubule cells, where it integrates signals from the protective arm of the renin-angiotensin system and the dopaminergic system (Jose et al., 2016, Am J Physiol Renal Physiol). Its main biological role is the regulation of sodium homeostasis; simultaneous activation by ligands like Angiotensin-(1-7) and dopamine produces a synergistic natriuretic effect. This synergy occurs through the inhibition of key renal sodium transporters, including Na+/K+-ATPase and the sodium-hydrogen exchanger 3 (NHE3). Dysregulation of the Mas-D2R heteromer is associated with the development of essential hypertension and impaired renal sodium handling. As a therapeutic target, the heteromer offers a pathway for developing antihypertensive treatments that may achieve higher efficacy with lower drug doses by exploiting receptor synergy. Research indicates that pharmacological agents like the Mas agonist AVE0991 and the D2R agonist quinpirole can modulate this complex to enhance renal function.

Other names
MAS1-DRD2 heteromerMas-D2 receptor complexAngiotensin-(1-7) receptor-Dopamine D2 receptor heteromer
02

Mechanism of action

The heteromer facilitates synergistic signaling between the Mas receptor and Dopamine D2 receptor, leading to the inhibition of renal sodium transporters such as Na+/K+-ATPase and NHE3, which promotes sodium excretion and reduces blood pressure (Li et al., 2014, Hypertension).

03

Biological functions

Signal transductionNatriuresisBlood pressure regulationRenal sodium handling
04

Disease associations

HypertensionRenal diseaseCardiovascular disease
05

Safety considerations

Potential central nervous system side effects due to D2R expression in the brainRisk of hypotensionElectrolyte imbalances
06

Interacting drugs

Angiotensin-(1-7)

4 more in the full profile.

07

Biomarkers

Urinary sodium excretionAngiotensin-(1-7) levelsRenal D2R expression levels

Beyond the preview

Go deeper on Mas proto-oncogene G protein-coupled receptor–Dopamine receptor D2 heteromer (Mas-D2R heteromer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mas proto-oncogene G protein-coupled receptor–Dopamine receptor D2 heteromer (Mas-D2R heteromer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call